Top 100 Trial Lawyers badge
BBB Accredited Business badge
Multi Million Dollar Advocates Forum badge
10 Best Attorney badge
top 10 trial lawyers badge
RUE Ratings Best Attorneys of aAmerica Badge
Veteran Approved Badge
Americas Top 100 Attorneys Badge
Lawyers of Distinction Badge
American Association for Justice Badge
Best Law Firms of America Badge
Top American Lawyers Badge
NADC Badge

A proposed piece of legislation recently introduced in the Pennsylvania House of Representatives purports to give relief to mesothelioma cancer victims who developed their disease through the course of their employment. The proposed law, House Bill 1234, would amend The Pennsylvania Occupational Disease Act (Act) to allow mesothelioma cancer victims to file for workers’ compensation claim.  The result, however, would arguably preclude mesothelioma victims common law claims against his employer making workers’ compensation the “exclusive remedy” barring the victims day in court.

As the law currently stands in the state of Pennsylvania, workers who develop an occupational disease as a result of their employment must do so within 300 weeks of their last workplace exposure or date of employment. Those who become aware of or receive their occupational disease diagnosis outside the 300-week statute of limitations are generally barred from receiving workers’ compensation benefits.  The Pennsylvania Supreme Court in Tooey v. AK Steel Corp., 623 Pa. 60 (2013) recognized that mesothelioma victims would have no remedy under the Act and held that the exclusivity provision does not preclude a plaintiff’s common law claims.

Unfortunately for those exposed to some carcinogens, their life-changing diagnosis is not received until many years after their last exposure due to the latency period associated with their condition. This is especially true for those who suffer from mesothelioma, a rare and deadly form of cancer caused by exposure to asbestos fibers in once common, everyday industrial and military applications.

A Louisiana federal judge recently denied a motion by the Ford Motor Co. which sought to throw out the asbestos cancer lawsuit, brought on behalf of the now deceased victim, alleging the automaker and others are responsible for the plaintiff’s injuries. While the same judge did rule partly in favor of Ford in limiting some of the claims brought against the company, the other asbestos-related claims may proceed against Ford and other named defendants.

According to the mesothelioma cancer lawsuit, filed in U.S. District Court for the  Eastern District of Louisiana, the victim developed peritoneal mesothelioma during his work as a mechanic and generator service technician. After filing his asbestos cancer lawsuit in a Louisiana state court in 2017, the case was removed to federal court the following year. Sadly, the victim passed away from his asbestos related cancer in 2018, leaving his surviving family to continue to action under a wrongful death claim.

In their lawsuit, the plaintiffs made claims against the Ford Motor Co. under Louisiana’s general negligence statute, employer liability statute, premises liability as owners of the premises where the victim worked, and product liability laws for manufacturing the asbestos laden products. In seeking to skirt liability, Ford claimed the plaintiffs were barred from recovering for any damages under the Louisiana Workers’ Compensation Act (LWCA) because the alleged injuries took place during the course of the victim’s employment.

June 29, 2019 – Announcing the selection of Michael Throneberry among America’s Top 100 High Stakes Litigators® for 2019.  Selection to America’s Top 100 High Stakes Litigators® is by invitation only and is reserved to identify the nation’s most exceptional trial attorneys in high value, high stakes legal matters.

To be considered for selection, an attorney must have litigated (for either plaintiff or defendant) a matter (1) with at least $2,000,000 in alleged damages at stake or (2) with the fate of a business worth at least $2,000,000 at stake. These minimum qualifications are required for initial consideration.  Thereafter, candidates are carefully screened through comprehensive Qualitative Comparative Analysis based on a broad array of criteria, including the candidate’s professional experience, litigation experience, significant case results, representative high stakes matters, peer reputation, and community impact in order to rank the candidates throughout the state.

Only the top 100 qualifying attorneys in each state will receive this honor and be selected for membership among America’s Top 100 High Stakes Litigators®.  With these extremely high standards for selection to America’s Top 100 High Stakes Litigators®, less than one-half percent (0.5%) of active attorneys in the United States will receive this honor — truly the most exclusive and elite level of attorneys in the community.

 A New York Supreme Court recently handed down an important ruling allowing a female plaintiff’s asbestos cancer lawsuit against cosmetics and pharmaceutical company Colgate-Palmolive to continue. The ruling comes after the court made a legal determination that it did in fact have jurisdiction in the case, potentially paving the way for other similar lawsuits in the state to be heard.

According to the lawsuit, filed in New York Supreme Court for New York County, the victim used talc-based products like Cashmere Bouquet manufactured and sold by Colgate-Palmolive on almost a daily basis in New York from 1979 through 1985. The lawsuit claims the plaintiff sometimes used the products more than once a day, even using so much talcum powder that the room she was in would become dusty, forcing her to sneeze.

The plaintiff claims that the Colgate-Palmolive talcum powder products she used were contaminated is carcinogenic asbestos and that she developed a serious form of lung cancer as a result of the asbestos exposure. The asbestos cancer lawsuit goes on to claim that despite knowing fully well about the potential dangers its talc-based products could pose to innocent consumers, the company decided against placing any warning labels alluding to the risks, including developing mesothelioma.

The Pennsylvania State Supreme Court recently heard arguments over how juries may apportion financial liability in asbestos cancer lawsuits as it relates to a state law passed in 2011 meant to provide clear guidance to courts in such matters. Despite the Pennsylvania Fair Share Act’s passage nearly a decade ago, Pennsylvania courts have inconsistently applied the laws as they relate to matters of strict liability, leaving it to the state’s highest court to sort out the appropriate application.

Under the Pennsylvania Fair Share Act, in matters of strict liability with multiple defendants (such as an asbestos cancer lawsuit) where juries find in favor of the plaintiff there must also be an apportionment of the liability to each negligent party, known as pro rata. Essentially, the law requires juries to prescribe a dollar amount each defendant owes separately to the plaintiff and other defendants are not responsible for the other’s apportionment of the judgement.

However, several of the state’s lower courts have inconsistently applied the 2011 version of the law as it pertains to mesothelioma cancer lawsuits, instead choosing to follow language from an earlier version of the same law. Under some courts’ interpretations, financial liability has been applied on a per capita basis, meaning each defendant pays an equal share of the damages awarded by the jury.

A New York City jury recently returned a substantial award in an asbestos talcum powder lawsuit brought by a woman who claims her rare and deadly form of cancer was caused by exposure to asbestos fibers in the talc-based products she used for decades. The lawsuit named pharmaceutical and cosmetics giant Johnson & Johnson as the defendant and alleged that the company knew for decades about the presence of carcinogens in its talcum powder products but provided no warning.

According to the mesothelioma cancer lawsuit, filed in New York City Supreme Court, the now 66-year-old plaintiff developed cancer from using talc-based products produced by Johnson & Johnson. Jurors hearing the case had already found in favor of the plaintiff, awarding the victim and her husband $25 million in compensatory damages for the couple’s economic damages as well as their pain and suffering from the wife’s mesothelioma cancer diagnosis.

This latest award included $300 million in punitive damages, a special type of compensation juries may sometimes be allowed to hand down in situations in which plaintiffs can demonstrate that the defendants were egregiously negligent in their conduct. Punitive damages are meant as a means to send a message and deter other similarly negligent conduct and protect the public.

A New York state jury recently handed down a substantial $25 million verdict in favor of a plaintiff who claims she developed an asbestos-related cancer after decades of using talcum powder products manufactured and sold by pharmaceutical and cosmetics giant Johnson & Johnson. The award includes compensatory damages for the victim’s medical bills and lost wages as well as the pain and suffering of living with the disease as well as damages for the plaintiff’s husband.

According to the lawsuit, filed in 2017 in New York City Supreme Court, the plaintiff used Johnson & Johnson’s Baby Powder and Shower to Shower almost daily from the time she was 8 years old until after she was married. Her attorneys claimed she developed mesothelioma from inhaling asbestos fibers in the talc.

In addition to the $25 million in compensatory damages, jurors will decide what if any punitive damages may be awarded to the plaintiffs. Punitive damages are a special type of award which courts may allow juries to hand down in cases in which plaintiffs have demonstrated that the level of misconduct by the defendants was so egregious that it warrants such damages as to deter other parties from acting in a similarly negligent manner.

Illinois Governor J.B. Pritzker recently signed into law a piece of legislation that would give workers who were exposed to deadly asbestos fibers the legal right to file civil lawsuits in court even after the workers’ compensation periods to file claims has expired. Until now, workers in Illinois had 25 years from the period of exposure to file claims for latent injuries with their employer’s workers’ compensation carrier, but the new law will give victims whose diseases do not present symptoms until after that period the chance to seek damages.

The legislation, originally introduced in the state senate under SB 1596, passed the General Assembly in a relatively short amount of time and went to the governor’s desk to be signed into law. The bill’s sponsor, Rep. Jay Hoffman, said the bill would allow workers diagnosed with mesothelioma, a rare and deadly form of lung cancer often caused by exposure to asbestos, a way to be compensated if symptoms do not present themselves until after the statute of limitations to file claims has expired.

However, despite the good intentions of the law to help the worker, pro-business and insurance lobbies will likely challenge the legislation claiming companies would be in a state of perpetual liability since workers now have the right to bring injury claims in civil court. Traditionally, injured workers must bring their claims through their employer’s workers’ compensation insurance carrier or their state’s administrative system for dealing with denied claims.

A recent report by Reuters news appears to suggest that while pharmaceutical and cosmetics giant Johnson & Johnson knew for decades about the risk of asbestos contamination in its talc-based products, the company continued to market and specifically target female minority communities. The revelations come after Johnson & Johnson settled two asbestos cancer lawsuits, one in Oklahoma and the other in California, during the middle of trial and settled another in New York just two-weeks before the start of proceedings.

According to the report, the “right place” to focus, according to a 2006 internal J&J marketing presentation, was “under-developed geographical areas with hot weather, and higher AA population,” the “AA” referring to African-Americans. Reuters also points out that Johnson & Johnson marketing executives sought to target overweight women, going as far as to request a significant increase in marketing funds over previous years to target overweight persons.

Since the 1970s, adults have been the main consumers of Johnson & Johnson’s Baby Powder and Shower to Shower products after pediatricians began to warn of the dangers to infants who inhale talc. By the mid-2000s, adults have accounted for over 90% of Baby Powder sales after Johnson & Johnson targeted its marketing efforts at a variety of demographics, including teens, the elderly, minority, and overweight females.

A Delaware federal judge recently denied a request by pharmaceutical and cosmetics giant Johnson & Johnson to remove thousands of asbestos cancer lawsuits from various state courts and place them all under the purview of a single jurisdiction. Johnson & Johnson made the request after its co-defendant and talc supplier in the lawsuits, Imerys Talc USA, filed for Chapter 11 bankruptcy protection under the weight of the litigation the two companies faced.

Johnson & Johnson had sought to invoke legal protections afforded to Imerys as a means to collect the estimated 2,400 talcum powder lawsuits under one federal judge and form a single defense strategy. Those claims alleged that Johnson & Johnson and Imerys Talc USA were responsible for the plaintiffs’ injuries due to the presence of asbestos fibers about which the two defendants knew but failed to provide any warnings to consumers.

Fortunately for the plaintiffs, who have yet to have their day in court, the judge hearing the motion denied Johnson & Johnson’s request. In her ruling the judge noted that “J&J cannot establish an emergency” tied to Imerys’ bankruptcy-reorganization effort. The judge went on to note that “J&J’s desire to centralize its own state-law litigation does not justify the finding of an emergency” requiring immediate transfer.

Contact Information